The North America Gene Therapy Market was valued at USD 0.00 in 2023 and is expected to reach USD 13,418.96 by 2030, growing at a CAGR of 18.8% (2024-2030).

The Middle East and Africa Gene Therapy Market was valued at USD 0.00 in 2023 and is expected to reach USD 1,019.11 by 2030, growing at a CAGR of 16.6% (2024-2030).

The Asia-Pacific Gene Therapy Market was valued at USD 0.00 in 2023 and is expected to reach USD 4,441.14 by 2030, growing at a CAGR of 19% (2024-2030).

The Europe Gene Therapy Market was valued at USD 0.00 in 2023 and is expected to reach USD 7,422.28 by 2030, growing at a CAGR of 17.6% (2024-2030).

The Global Gene Therapy Market was valued at USD 10.26 Billion in 2024 and is expected to reach USD 39.38 Billion by 2032, growing at a CAGR of 18.3% (2025-2032).